Debut Plus

₹1,164.2

▼ -33.29 -2.78%

As of 23 Oct 2026 · delayed

NSE Listed

Symbiotec Pharmalab Ltd. (SYMBIOTEC)

Volume: 2,58,232Avg Vol 1W: 5,00,862Avg Vol 1M: 12,15,21052W Range:₹934.2₹1,309.9
NSE BSE www.symbiotec.com
Key Ratios
Checked 5h ago
Market Cap₹7,481 Cr
Current Price₹1,164.2
Previous Close₹1,197.49
High / Low (52w)₹1,309.9 / ₹934.2
Volume2,58,232
Avg Vol (1W)5,00,862
Avg Vol (1M)12,15,210
Stock P/E64.86
Book Value₹202.32
Dividend Yield0%
ROE9.56%
ROA447.4%
Revenue (TTM)—
Revenue Growth—
Profit Margin10.73%
Total Debt—
Shares Outstanding6 Cr
Face Value—
EPS (TTM)₹17.95
P/B5.75
Debt / Equity0.48
50 DMA—
200 DMA—
Day change-2.78%
Price Chart
₹1,164.2▲ 6.06% · 1Y
₹1280₹10033.0Cr
2026-09-01
2026-10-23

20-day avg volume: 11.6L shares

Pros
  • Company is almost debt-free.
Cons
  • Stock trades at a high P/E of 65.
Quarterly Results
MetricJun 2025Mar 2026Jun 2026
Revenue₹203 Cr₹245 Cr₹218 Cr
EBITDA₹50 Cr₹43 Cr₹24 Cr
Net Profit₹30 Cr₹28 Cr₹14 Cr
EPS———
Profit & Loss (Annual)
MetricMar 2022Mar 2023Mar 2024Mar 2025Jun 2025Mar 2026Mar 2026Jun 2026
Revenue₹685 Cr₹573 Cr₹723 Cr₹756 Cr₹204 Cr₹213 Cr₹872 Cr₹211 Cr
EBITDA₹107 Cr₹47 Cr₹140 Cr₹163 Cr₹65 Cr₹56 Cr₹188 Cr₹69 Cr
Net Profit₹78 Cr₹23 Cr₹100 Cr₹97 Cr₹45 Cr₹-16 Cr₹110 Cr₹47 Cr
EPS7121.4891.4988.5——19—
Balance Sheet
MetricMar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Total Assets₹768 Cr₹815 Cr₹990 Cr₹1,295 Cr₹1,580 Cr₹1,781 Cr
Total Liabilities₹248 Cr₹217 Cr₹369 Cr₹580 Cr₹765 Cr₹631 Cr
Equity₹521 Cr₹599 Cr₹621 Cr₹715 Cr₹815 Cr₹1,150 Cr
Total Debt——————
Cash Flow
MetricMar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Operating₹217 Cr₹47 Cr₹87 Cr₹222 Cr₹82 Cr₹236 Cr
Investing₹-96 Cr₹-32 Cr₹-220 Cr₹-206 Cr₹-307 Cr₹-227 Cr
Financing₹-79 Cr₹15 Cr₹146 Cr₹22 Cr₹278 Cr₹36 Cr
Free Cash Flow₹217 Cr₹47 Cr₹87 Cr₹222 Cr₹82 Cr₹236 Cr
Shareholding
Promoter 33.28% Institutions 36.96% Public 29.76%
Efficiency & Working Capital
ROCE11.6%
Interest Coverage6.9
Dividend Payout—
Debtor Days83 d
Inventory Days99 d
Payable Days58 d
Cash Conversion Cycle124 d
Working Capital Days182 d
Shareholding Details

As of 2026-09-30

Promoter33.3%
FII3.8%
DII33.2%
Institutions37%
Public29.8%
Promoter Pledge38.5%
No. of Shareholders81,747
Shareholding Pattern

Quarterly — figures in %. Latest 3 quarters.

PeriodDec 2025Aug 2026Sept 2026
Promoters35.1%33.3%33.3%
FIIs0%21.1%3.8%
DIIs0%27.5%33.2%
Public64.9%18.1%29.8%
Promoter Pledge0%0%38.5%
No. of Shareholders154,27,73081,747
Returns History (ROE / ROCE / ROA)
PeriodROEROCEROAP/E
202503————
Major Shareholders (>1%)
NameCategoryStakeShares
Satwani Holdings LlpShareholding of Promoter and Promoter Group15.3%98,19,885
Rosewood InvestmentsPublic Shareholding14.1%90,42,092
Business Excellence Trust Iii - India Business Excellence Fund IiiPublic Shareholding10.2%65,78,995
Mirae Asset Aggressive Hybrid FundPublic Shareholding6%38,53,793
Anil SatwaniShareholding of Promoter and Promoter Group4.4%28,10,896
Kashish SatwaniShareholding of Promoter and Promoter Group4.3%27,50,896
Anil SatwaniShareholding of Promoter and Promoter Group3.4%21,99,104
Anil SatwaniShareholding of Promoter and Promoter Group3.4%21,99,104
Valuequest Founders Conviction LvfPublic Shareholding2.9%18,76,291
Think India Opportunities Master Fund LpPublic Shareholding2.8%17,71,255
Sushil SatwaniShareholding of Promoter and Promoter Group1.9%12,33,938
Pi Opportunities Aif V LlpPublic Shareholding1.8%11,45,737
Dymon Asia Multi-strategy Investment (singapore) Pte. LtdPublic Shareholding1.6%10,12,145
Icici Prudential Smallcap FundPublic Shareholding1.6%9,97,290
Motilal Oswal Small Cap FundPublic Shareholding1.5%9,29,089
Vq Fastercap Fund IiPublic Shareholding1%6,60,435
Anil SatwaniShareholding of Promoter and Promoter Group0.5%3,50,000
Sunil SatwaniShareholding of Promoter and Promoter Group0%10,000
Swati SachdevShareholding of Promoter and Promoter Group0%10,000
Promoter Pledges
HolderPledged Shares% of HoldingAs of
Anil Satwani4,50,89616%2026-09-30
Kashish Satwani5,00,89618.2%2026-09-30
Anil Satwani21,99,104100%2026-09-30
Anil Satwani21,99,104100%2026-09-30
Sushil Satwani3,13,93825.4%2026-09-30
Anil Satwani3,50,000100%2026-09-30
Satwani Holdings Llp22,27,73422.7%2026-09-30
Board of Directors
NameDesignationYear
ANIL KUMAR SATWANIChairman / Executive Director / M D / Promoter2026
Sunita KishnaniIndependent Non Exe. Director2026
PRATIK PATELIndependent Non Exe. Director2026
Pramod KasatIndependent Non Exe. Director2026
ROHIT BRIJMOHAN MANTRINominee2026
Dhananjay N MungaleNominee2026
Salil JainCompany Sec. & Compli. Officer2026
Segments — Geography
RegionRevenueShare
India₹342 Cr45.2%
Outside india₹415 Cr54.8%
Capital Structure (₹ Cr)
YearFace ValueAuthorisedIssuedPaid-up
2025₹10301111
Related-Party Transactions (₹ Cr)
YearSubsidiariesAssociatesJVKMPOthersTotal
202421700011227
20241990000199
202450001115
Insider / Designated-Person Trades

16 recent disclosure(s)

SACHIN MADHUKAR CHAUDHARIDisposal · 2,500
RAMAN PRASAD VERMADisposal · 17,000
RAJESH BHIMRAO MESHRAMDisposal · 7,000
NISHIKANT Digambar GHADGEDisposal · 1,000
MITESH PATELDisposal · 11,500
JITENDRA SHARMADisposal · 9,200
Company Information
Incorporated2002
ChairmanANIL KUMAR SATWANI
AuditorSRBC & Co LLP
Investor Email[email protected]
🌐 www.symbiotec.com ↗

📍 385/2 Pigdamber Near, Mashal Hotel Rau, Indore, Madhya Pradesh, 453331

Technical AnalysisPremium

Technical analysis (Premium)

Log in to see RSI, MACD, moving averages, oscillators and pivot levels for this stock.

Log inSign up free

More stocks

Swastika Infra LimitedSwelect Energy Systems Ltd.Swiggy LimitedSwiss Military Consumer Goods Ltd.Sterling & Wilson Renewable Energy Ltd.Sylvan Plyboard (India) LimitedSymphony LimitedSyncom Formulations (India) Ltd.Syngene International Ltd.Synoptics Technologies LimitedSyrma SGS Technology Ltd.Systango Technologies Ltd.All “S” stocks →

Prices are delayed/indicative; pros & cons are AI generated. Informational only — not investment advice. ← Back to search